These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30609164)

  • 21. Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations.
    Ueberall MA; Mueller-Schwefe GH
    Curr Med Res Opin; 2015; 31(7):1413-29. PubMed ID: 25942606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy.
    Comelon M; Wisloeff-Aase K; Raeder J; Draegni T; Undersrud H; Qvigstad E; Bjerkelund CE; Lenz H
    Acta Anaesthesiol Scand; 2013 Apr; 57(4):509-17. PubMed ID: 23301686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
    Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C
    Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR.
    Dupoiron D; Stachowiak A; Loewenstein O; Ellery A; Kremers W; Bosse B; Hopp M
    Eur J Pain; 2017 Oct; 21(9):1528-1537. PubMed ID: 28641363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancer.
    Clemens KE; Quednau I; Klaschik E
    Int J Clin Pract; 2011 Apr; 65(4):472-8. PubMed ID: 21401835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of modified two-point dixon and chemical shift encoded MRI water-fat separation methods for fetal fat quantification.
    Giza SA; Miller MR; Parthasarathy P; de Vrijer B; McKenzie CA
    J Magn Reson Imaging; 2018 Jul; 48(1):274-282. PubMed ID: 29319918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users.
    Setnik B; Schoedel K; Bartlett C; Dick C; Hakim N; Geoffroy P
    J Opioid Manag; 2017; 13(6):449-464. PubMed ID: 29308591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms underlying effects of kiwifruit on intestinal function shown by MRI in healthy volunteers.
    Wilkinson-Smith V; Dellschaft N; Ansell J; Hoad C; Marciani L; Gowland P; Spiller R
    Aliment Pharmacol Ther; 2019 Mar; 49(6):759-768. PubMed ID: 30706488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans.
    Jeong ID; Camilleri M; Shin A; Iturrino J; Boldingh A; Busciglio I; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Aliment Pharmacol Ther; 2012 May; 35(9):1088-96. PubMed ID: 22348605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone.
    Mandema JW; Kaiko RF; Oshlack B; Reder RF; Stanski DR
    Br J Clin Pharmacol; 1996 Dec; 42(6):747-56. PubMed ID: 8971431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a double-blind, randomized, placebo- and oxycodone controlled release-controlled study.
    Serrie A; Lange B; Steup A
    Curr Med Res Opin; 2017 Aug; 33(8):1423-1432. PubMed ID: 28537501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.
    Lazzari M; Greco MT; Marcassa C; Finocchi S; Caldarulo C; Corli O
    Drug Des Devel Ther; 2015; 9():5863-72. PubMed ID: 26586937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of tapentadol prolonged release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled release-controlled studies.
    Lange B; von Zabern D; Elling C; Dubois C
    Curr Med Res Opin; 2017 Aug; 33(8):1413-1422. PubMed ID: 28537506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
    Kopecky EA; Vaughn B; Lagasse S; O'Connor M
    Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation.
    Leppert W; Zajaczkowska R; Wordliczek J
    Expert Opin Pharmacother; 2019 Apr; 20(5):511-522. PubMed ID: 30625013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic Resonance Imaging Quantification of Fasted State Colonic Liquid Pockets in Healthy Humans.
    Murray K; Hoad CL; Mudie DM; Wright J; Heissam K; Abrehart N; Pritchard SE; Al Atwah S; Gowland PA; Garnett MC; Amidon GE; Spiller RC; Amidon GL; Marciani L
    Mol Pharm; 2017 Aug; 14(8):2629-2638. PubMed ID: 28648070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of motion of colonic contents in the human colon using MRI tagging.
    Pritchard SE; Paul J; Major G; Marciani L; Gowland PA; Spiller RC; Hoad CL
    Neurogastroenterol Motil; 2017 Sep; 29(9):. PubMed ID: 28439942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.